About 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
The next step towards changing treatment paradigms in immuno-oncology.
The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Bispecific Antibodies and Cell Therapies.
Clinical trials have showed that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy.
It’s clearly one of the hottest fields of Biopharma which has gained momentum in the past few years.
For More Info visit event links:
Login for Event's Registration
To proceed with the event's registration, please Login
